(Date:7/2/2009)...GO, July 2 Recent news ...an credentials and ensuring that physicians meet h...cording to the American Board of Medical Specialti...mber Boards in their efforts to develop and implem... evaluation and certification of physician special...
(Date:7/2/2009)... Health one of 63 businesses honored in Washington...e-USNewswire/ -- Texas Health Resources has rece...ward from the National Business Group on Health. ,...h/20090702/DC41773LOGO ) , , The award recog...tive programs that promote a healthy workplace and...
(Date:7/2/2009)...sleep aid shuts down one set of neurons, another s... (HealthDay News) -- New information about brain c...ho take the sleep aid Ambien (zolpidem) walk, eat,...awake -- and without remembering it the next morni...nimally conscious patients into a conscious state....
(Date:7/2/2009)...N, Fla., July 2 American...oday announced that the Company,s Acting CFO, Ms. ...-time to the position and has resigned from her cu... , Ms. McWilliams has held various positions as...She possesses in-depth, practical knowledge in cas...
Breaking Medicine News(10 mins):Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2Health News:American Scientific Resources Announces Acting CFO Transition to Full-Time 2...ositive female drug injection users in US and Sout... partners, according to a new study. // "Forty per...having sex with at-risk male partners, and more th...used consistently," said lead author Dr. Mary H. L...
...orld Health Organisation confirmed the 42nd human ...par with Vietnam as the two worst-hit by the virus... said here on Thursday. "The result was positive,...ratory in Hong Kong today," Hariadi Wibisono, the ...
...tists from the University of Cincinnati have come ...od obesity.// This issue has become an important ...ty. In the spring season the researchers recruited... in Meade County, Ky to fight childhood obesity. T...
...ding to a study conducted by the researchers at th...e in the prevalence of a particular type of heart ...f 15 years and it revealed the fact that there is ...failure. Statistics show that diastolic heart fail...
Other Medicine News:Health News:New Preventive Strategy to Fight Childhood Obesity 2Health News:Diastolic Heart Failure on the Rise 2(Date:6/28/2009)...ne 29 , - Study Triggers $7...roup Corporation ("Sosei"; TSE Mothers Index: 4565...ounce the commencement of a Phase III,clinical st...cting muscarinic,antagonist (LAMA) for the treatm...D). NVA237 is a dry powder formulation for oral in...
(Date:6/26/2009)...netic Mutations Acting Together-- , , PHILADELP...s in the complex autism inheritance puzzle are eme...luding geneticists from The Children,s Hospital of...hool of Medicine and several collaborating institu...regions where rare copy number variations - missin...
(Date:6/25/2009)... -- "Congratulations President Obama on your agree...escription costs for the elderly," says Mark D. St...ught you should know that you have a little compan... sufferers of all ages." , , Mr. Steele is spea...sion of their findings from a recent clinical stud...
(Date:6/24/2009)...ire-FirstCall/ -- , - Recruitment on Track ...cal Treatment of Eye Disease With No Reported Safe...sels: THR), a biotechnology company,focused on th...ts for eye,disease, vascular disease and cancer, ...n, which is in Phase III trials for the treatment ...
Breaking Medicine Technology:Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3Lowest Blood Pressure Cholesterol Levels the Best 40381 1Lowest Blood Pressure Cholesterol Levels the Best 40381 2Lowest Blood Pressure Cholesterol Levels the Best 40381 3Federal Court Rules FDA Must Reconsider Plan B Decision 40378 1Federal Court Rules FDA Must Reconsider Plan B Decision 40378 2Federal Court Rules FDA Must Reconsider Plan B Decision 40378 3Jonathan Finder M D Joins Point Pleasant Pediatric Special Cares Medical Management Team as Pulmonary Consultant 40374 1Susan G Komen for the Cure 28R 29 Advocacy Alliance Supports Effort to Encourage Early Breast Health Education 40370 1Susan G Komen for the Cure 28R 29 Advocacy Alliance Supports Effort to Encourage Early Breast Health Education 40370 2...wire-FirstCall/ --,Medivation, Inc. today announce...Eastern time on Monday, June 11, to discuss top-li...ind,placebo-controlled Phase 2 clinical trial of ...mer,s disease. , Rachelle Doody, M.D., Ph.D., lead...onth results for the first time at a,scientific me...
...ire/ -- , Professor Home said: , "The editorials p...ing in that they disregarded important pieces of d...ysicians. Most,significantly the editorials ignore...cardiovascular death or death from any,cause." , P...ome, (44) 778-525-1736 , Terms and conditions of ...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Aplicare's Saturated Swabsticks are packaged in easy open, single-use foil-laminated pouches. Each 4 inch Swabstick is saturated with precisely the correct amount of solution. Each package is termina
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks.
Triad Plus PVP-I Prep Solution has broad-spectrum germicidal action. Povidone Iodine Solution using an innovative one-piece screw cap, Triad Plus bottles are designed specifically to meet the needs o
Aplicare's saturated swabsticks are packaged in easy open, single use, foil-laminated pouches. Each 4 inch swabstick is saturated with precisely the correct amount of Povidone Iodine gel. The Gel Swa
Medicine Products: